Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/119365
Title: | Type 2 amiodarone-induced thyrotoxicosis in a patient with positive thyroid-stimulating hormone-receptor antibodies |
Authors: | Piscopo, Naomi Soler, Samuel F. Mifsud, Simon Vella, Sandro |
Keywords: | Amiodarone Hyperthyroidism Thyrotropin Hormone receptors |
Issue Date: | 2023 |
Publisher: | MA Healthcare Ltd |
Citation: | Piscopo, N., Soler, S. F., Mifsud, S., & Vella, S. (2023). Type 2 amiodarone-induced thyrotoxicosis in a patient with positive thyroid-stimulating hormone-receptor antibodies. British Journal of Hospital Medicine, 84(2), 1-3. |
Abstract: | The authors present a case of type 2 amiodarone-induced thyrotoxicosis in a 55-year-old man with positive thyroid-stimulating hormone-receptor antibodies, who had not been taking amiodarone for 8months. This case highlights that the presence of thyroid-stimulating hormone-receptor antibodies does not necessarily imply the development of Graves’ disease. It also demonstrates that amiodarone-induced thyrotoxicosis can present several months after withdrawal of amiodarone treatment. In this case, the rapid and dramatic drop in free triiodothyronine levels with glucocorticoid therapy suggested type 2 amiodarone-induced thyrotoxicosis. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/119365 |
Appears in Collections: | Scholarly Works - FacM&SMed |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Type_2_amiodarone_induced_thyrotoxicosis_in_a_patient_with_positive_thyroid_stimulating_hormone_receptor_antibodies_2023.pdf Restricted Access | 72.41 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.